date,title,source
Oct-17-18,"BioLineRx, High Potential Near Term Catalysts, Analysts Review and Target",ACCESSWIRE
Oct-19-18,BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress,PR Newswire
Nov-01-18,"BioLineRx to Report Third Quarter 2018 Results on November 8, 2018",PR Newswire
Nov-08-18,BioLineRx Reports Significant Progress Across Oncology Programs and Provides Third Quarter Financial Update,PR Newswire
Nov-16-18,"Recent Analysis Shows BioLineRx, Interlink Electronics, IMV INC, PAR Technology, Hudson Global, and Identiv Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-20-18,New Healthcare Trends Have Investors Looking at 4 Stocks,ACCESSWIRE
Nov-20-18,BioLineRx Announces Receipt of FDA Biological Product Designation for Novel Cancer Immunotherapy Candidate AGI-134,PR Newswire
Dec-06-18,"BioLineRx to Host Investor and Analyst Breakfast Meeting on December 11, 2018 in New York",PR Newswire
Dec-11-18,BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration,PR Newswire
Jan-02-19,BioLineRx to Present at the 2019 Biotech Showcase,PR Newswire
Feb-04-19,BioLineRx Announces Proposed Underwritten Public Offering of its American Depositary Shares and Warrants,PR Newswire
Feb-04-19,Watch These 4 Healthcare Stocks Set The Pace On Monday (2/4/19),ACCESSWIRE
Feb-04-19,BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer,PR Newswire
Feb-05-19,BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants,PR Newswire
Feb-05-19,Biotech on the Brink of Breaking Out,ACCESSWIRE
Feb-05-19,BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants,PR Newswire
Feb-05-19,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",Benzinga
Feb-07-19,BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants,PR Newswire
Feb-07-19,BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants,PR Newswire
Mar-14-19,BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference,PR Newswire
Mar-21-19,"BioLineRx to Report Annual 2018 Results on March 28, 2019",PR Newswire
Mar-27-19,Four Tech Stocks Sparking Activity on Wednesday,ACCESSWIRE
Mar-27-19,BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients,PR Newswire
